Scholars Central

Conference abstractPublished 2018

Vesicular zinc depletion by acamprosate reduces traumatic brain injury-induced hippocampal neuron death

Authors: Sang Won Suh, Bo Young Choi, Song Hee Lee, Hui Chul Choi, Hong Ki Song, Sang-Kyu Lee, Min Sohn

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Acamprosate or N-acetyl homotaurine is a N-methyl-D-aspartate (NMDA) receptor antagonist that is used as a pharmacological means of treatment for chronic alcohol dependence. Although the exact mechanism of acamprosate has not been clearly established, it appears to work by promoting a balance between the excitatory and inhibitory neurotransmitters, glutamate and gamma-aminobutyric acid (GABA), respectively. Several studies have demonstrated that acamprosate provides neuroprotection against cerebral ischemia-induced brain injury. However, there are no studies investigating the role of acamprosate on traumatic brain injury (TBI) induced neuronal death. In the present study, we sought to analyze the therapeutic potential of acamprosate to protect against neuronal death and other underlying pathogenic mechanisms that arise following TBI. Rats were given acamprosate (200 mg/kg) orally once per day for two weeks. Two week later, rats were subjected to a controlled cortical impact (CCI; 5 m/sec, 500 ms duration, 5 mm deformation) injury over the right parietal cortex. Histological analysis was performed at 3 or 24 hours, or 7 days after TBI. We found that acamprosate treatment for 2 weeks reduces levels of vesicular glutamate and zinc in the hippocampus. Consequently, this reduced vesicular glutamate and zinc level resulted in reduction of ROS production at 3 hours after TBI. When evaluated at 24 hours after TBI, acamprosate administration reduced the number of degenerating neurons, blood-brain barrier (BBB) disruption, leukocyte infiltration and dendritic loss. Acamprosate also reduced glial activation and neuronal loss at 7 days after TBI. In addition, acamprosate rescued TBI-induced cognitive dysfunction. The present study demonstrates that acamprosate attenuates TBI-induced brain damage by depletion of vesicular glutamate and zinc levels. Therefore, the present study suggests that acamprosate may have a high therapeutic potential for prevention of TBI-induced neuronal death.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neurology & Neurophysiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology & Neurophysiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Sang Won Suh”
  • BylineArticles whose byline prints “Bo Young Choi”
  • BylineArticles whose byline prints “Song Hee Lee”
  • BylineArticles whose byline prints “Hui Chul Choi”
  • BylineArticles whose byline prints “Hong Ki Song”
  • BylineArticles whose byline prints “Sang-Kyu Lee”
  • BylineArticles whose byline prints “Min Sohn”